Despite Criticisms – Dsuvia (Sufentanil) made it's way to market

Visual MD

Nov 4, 2018

New Drug Approval ( 28 Sept 2018 – 30 October 2018)

Visual MD

Nov 3, 2018

FDA Approves Lorbrena (lorlatinib) for Previously-Treated ALK-Positive Metastatic Non-Small Cell Lun

Visual MD

Nov 3, 2018

FDA Approves Lorbrena (lorlatinib) for Previously-Treated ALK-Positive Metastatic Non-Small Cell Lun

Visual MD

Nov 3, 2018

FDA permission for diagnostic test to aid in the determination of menopausal status

Visual MD

Oct 24, 2018

FDA approves first cancer treatment for any solid tumor with a specific genetic feature

Visual MD

May 23, 2017

Autism: Beware of Potentially Dangerous Therapies and Products

Visual MD

Apr 30, 2017

FDA action against 14 companies for selling illegal cancer treatments

Visual MD

Apr 27, 2017

A new eczema drug Dupixent : FDA Approval

Visual MD

Mar 28, 2017

56789